Home page arrow Research lines arrow Research line 3

Research line 3

RL 3: Measurement of biomarkers to estimate individualised CVD risk profiles

 

The overall goal of this Research Line is to measure biomarkers of intermediate pathways and genetic make-up and analyse their impact on individualised CVD prediction.

 

Research Line specific objectives:

 

to assess the impact of Lp-PLA2, NT-proBNP, and sensitive cardiac troponin-T on CVD risk prediction;

 

to assess the impact of common SNPs on CVD risk prediction; and

 

to assess the impact of telomere length on CVD risk prediction.